A meeting with the maven of mRNA therapeutics
Katalin Karikó inspires RNAmed graduate students in Würzburg
On July 26, the RNAmed graduate program was kicked off with an exclusive Q&A session between the RNAmed students and Katalin Karikó, a pioneer in the area of mRNA vaccines and therapeutics. The RNAmed kick-off saw students travel from Munich and Regensburg to the Biocenter at the Julius-Maximilians-Universität of Würzburg, where Karikó was also honored with the 'Theodor Boveri Prize' by the Würzburg Physical Medical Society. This was in recognition of her outstanding contributions to mRNA therapeutics, bridging basic sciences with therapeutic applications, unlocking a whole new field in biomedical research.
During her visit, the RNAmed students had the distinct pleasure of engaging with this living legend. Karikó spoke candidly about her research journey, including the toils, trials and triumphs that led to the use of mRNA as a therapeutic. Her discoveries have not only protected millions from the new coronavirus, but Karikó’s work has far-reaching implications, extending to other infectious, cancer and hereditary diseases.
We extend our heartfelt gratitude to Katalin Karikó for igniting passion and inspiration in the next generation of RNA researchers at RNAmed.
